Schedule of Warrants to Purchase Common Stock Outstanding (Details) |
12 Months Ended |
|---|---|
|
Dec. 31, 2023
$ / shares
shares
| |
| Exercise price maximum | $ 0.10 |
| Shares underlying warrants outstanding | shares | 10,892,000 |
| Weighted average remaining contractual term | 7 years 2 months 26 days |
| Weighted average exercise price | $ 0.14 |
| Shares underlying warrants outstanding | shares | 10,392,000 |
| Weighted average exercise price | $ 0.14 |
| Warrant [Member] | |
| Shares underlying warrants outstanding | shares | 14,011,650 |
| Weighted average remaining contractual term | 1 year 10 months 28 days |
| Weighted average exercise price | $ 0.29 |
| Shares underlying warrants outstanding | shares | 14,011,650 |
| Weighted average exercise price | $ 0.29 |
| Warrant [Member] | Minimum [Member] | |
| Exercise price maximum | 0.25 |
| Warrant [Member] | Maximum [Member] | |
| Exercise price maximum | $ 0.50 |
| X | ||||||||||
- Definition The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|